Laboratory Analytical Instruments - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the Laboratory industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

Laboratory Analytical Instruments - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - Laboratory Analytical Instruments
Corporate Insider Buy Sell Ratio (Insider Count) - Laboratory Analytical Instruments
Laboratory Analytical Instruments - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Security Form Insider Code 10b5-1 Direct Share
Price
Shares
Changed
2025-09-04 NAUT / Nautilus Biotechnology, Inc. 4 Murphy Matthew B. P - Purchase I 0.6429 20,000
2025-09-02 A / Agilent Technologies, Inc. 4 MCDONNELL PADRAIG S - Sale D 124.88 -2,000
2025-09-02 SEER / Seer, Inc. 4 Ro Isaac A - Award D 41,000
2025-09-01 BIO / Bio-Rad Laboratories, Inc. 4 BARRY JAMES M - Exercise D 602
2025-09-01 BIO / Bio-Rad Laboratories, Inc. 4 COREY COLLEEN M - Exercise D 1,102
2025-09-01 BIO / Bio-Rad Laboratories, Inc. 4 SCHWARTZ NORMAN D M - Exercise D 6,353
2025-09-01 BIO / Bio-Rad Laboratories, Inc. 4 Allison Schwartz M - Exercise D 147
2025-09-01 BIO / Bio-Rad Laboratories, Inc. 4 Allison Schwartz F - Taxes D 297.88 -55
2025-09-01 BIO / Bio-Rad Laboratories, Inc. 4 BARRY JAMES F - Taxes D 297.88 -217
2025-09-01 BIO / Bio-Rad Laboratories, Inc. 4 COREY COLLEEN F - Taxes D 297.88 -398
2025-09-01 BIO / Bio-Rad Laboratories, Inc. 4 SCHWARTZ NORMAN D F - Taxes D 297.88 -3,084
2025-08-31 QTRX / Quanterix Corporation 4 Toloue Masoud F - Taxes D 4.55 -254
2025-08-27 RVTY / Revvity, Inc. 4 MICHAS ALEXIS P By The Cayre and Alexis Michas Foundation Corp. S - Sale I 89.01 -500
2025-08-22 TXG / 10x Genomics, Inc. 4 Taich Adam S - Sale D 13.787 -22,315
2025-08-22 TXG / 10x Genomics, Inc. 4 Hindson Benjamin J. S - Sale D 13.787 -7,486
2025-08-22 TXG / 10x Genomics, Inc. 4 Saxonov Serge S - Sale D 13.787 -9,348
2025-08-21 AVTR / Avantor, Inc. 4 SUMME GREGORY L By a Trust P - Purchase I 12.56 100,000
2025-08-20 SEER / Seer, Inc. 4 Horn David R. S - Sale D 2.0441 -6,827
2025-08-20 SEER / Seer, Inc. 4 Farokhzad Omid S - Sale D 2.0441 -33,992
2025-08-20 SCND / Scientific Industries, Inc. 4 MOORE JOHN A A - Award D 1 30,000
2025-08-19 MTD / Mettler-Toledo International Inc. 4 Vadala Shawn S - Sale D 1325.00 -300
2025-08-19 MTD / Mettler-Toledo International Inc. 4 Vadala Shawn M - Exercise D 397.95 300
2025-08-18 PACB / Pacific Biosciences of California, Inc. 4 Van Oene Mark S - Sale D 1.311 -26,836
2025-08-18 CTKB / Cytek Biosciences, Inc. 4 Barnett Valerie M - Exercise D 7,735
2025-08-18 CTKB / Cytek Biosciences, Inc. 4 Busque Philippe M - Exercise D 3,625
2025-08-18 CTKB / Cytek Biosciences, Inc. 4 McCombe William D. M - Exercise D 13,051
2025-08-18 CTKB / Cytek Biosciences, Inc. 4 Barnett Valerie M - Exercise D 3,681
2025-08-18 CTKB / Cytek Biosciences, Inc. 4 Busque Philippe M - Exercise D 2,210
2025-08-18 CTKB / Cytek Biosciences, Inc. 4 McCombe William D. M - Exercise D 6,320
2025-08-18 CTKB / Cytek Biosciences, Inc. 4 Yan Ming M - Exercise D 1,981
2025-08-18 CTKB / Cytek Biosciences, Inc. 4 Holder Michael M - Exercise D 2,181
2025-08-18 CTKB / Cytek Biosciences, Inc. 4 Busque Philippe M - Exercise D 1,536
2025-08-18 CTKB / Cytek Biosciences, Inc. 4 Yan Ming M - Exercise D 6,162
2025-08-18 CTKB / Cytek Biosciences, Inc. 4 Yan Ming M - Exercise D 7,363
2025-08-18 CTKB / Cytek Biosciences, Inc. 4 Chin Richard M - Exercise D 4,071
2025-08-18 CTKB / Cytek Biosciences, Inc. 4 Yan Ming M - Exercise D 5,525
2025-08-18 CTKB / Cytek Biosciences, Inc. 4 Barnett Valerie M - Exercise D 2,016
2025-08-18 CTKB / Cytek Biosciences, Inc. 4 Barnett Valerie M - Exercise D 10,875
2025-08-18 CTKB / Cytek Biosciences, Inc. 4 Jiang Wenbin M - Exercise D 29,002
2025-08-18 CTKB / Cytek Biosciences, Inc. 4 Jiang Wenbin M - Exercise D 22,100
2025-08-18 CTKB / Cytek Biosciences, Inc. 4 Jiang Wenbin M - Exercise D 11,781
2025-08-18 CTKB / Cytek Biosciences, Inc. 4 Jiang Wenbin M - Exercise D 6,758
2025-08-18 CTKB / Cytek Biosciences, Inc. 4 Jiang Wenbin F - Taxes D 4.06 -7,062
2025-08-18 CTKB / Cytek Biosciences, Inc. 4 Jiang Wenbin F - Taxes D 4.06 -5,382
2025-08-18 CTKB / Cytek Biosciences, Inc. 4 Jiang Wenbin F - Taxes D 4.06 -1,646
2025-08-18 CTKB / Cytek Biosciences, Inc. 4 Jiang Wenbin F - Taxes D 4.06 -2,869
2025-08-18 CTKB / Cytek Biosciences, Inc. 4 Barnett Valerie F - Taxes D 4.06 -786
2025-08-18 CTKB / Cytek Biosciences, Inc. 4 Yan Ming F - Taxes D 4.06 -1,498
2025-08-18 CTKB / Cytek Biosciences, Inc. 4 McCombe William D. F - Taxes D 4.06 -5,084
2025-08-18 CTKB / Cytek Biosciences, Inc. 4 Busque Philippe F - Taxes D 4.06 -599
P
Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.
S
Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi turunan
D
Penjualan atau pengalihan sekuritas kembali ke perusahaan.
F
Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.
G
Pemberian sekuritas oleh atau kepada orang dalam.
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Transaksi yang dilaporkan secara sukarela pada Formulir 4.
J
Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)